表皮转录因子Ovol1协同调控银屑病样炎症中的屏障维持与中性粒细胞聚集
该研究利用皮肤上皮特异性Ovol1缺失小鼠,发现Ovol1缺失损害表皮屏障并加重银屑病样皮肤炎症,部分通过增强中性粒细胞聚集和脓肿形成实现。分子研究鉴定IL-33和Cxcl1为Ovol1的潜在直接靶基因,功能实验表明升高的Il33表达减轻疾病严重度,而中性粒细胞持续聚集和表皮迁移则加剧炎症。
要点
- Ovol1缺失损害表皮屏障并加重银屑病样炎症
- IL-33和Cxcl1是Ovol1的潜在直接靶基因
- 升高的Il33减轻疾病,中性粒细胞聚集加剧炎症
核心结论
- 表皮表达的转录因子Ovol1同时调控表皮屏障完整性和银屑病样炎症中的中性粒细胞行为。
研究设计与样本
- 研究采用皮肤上皮特异性Ovol1缺失小鼠,并结合分子研究和功能实验。
主要发现
- Ovol1缺失损害表皮屏障并加重小鼠银屑病样皮肤炎症,部分通过增强中性粒细胞聚集和脓肿形成。
- IL-33和Cxcl1被鉴定为Ovol1的潜在弱和强直接靶基因。
- 升高的Il33表达减轻咪喹莫特处理的Ovol1缺陷小鼠的疾病严重度,而中性粒细胞持续聚集和表皮迁移加剧疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Skin epidermis constitutes the exterior barrier that protects the body from dehydration and environmental assaults. Barrier defects underlie common inflammatory skin diseases, but the molecular mechanisms that maintain barrier integrity and regulate epidermal-immune cell cross-talk in inflamed skin are not fully understood. In this study, we show that skin epithelia-specific deletion of Ovol1, which encodes a skin disease‒linked transcriptional repressor, impairs the epidermal barrier and aggravates psoriasis-like skin inflammation in mice in part by enhancing neutrophil accumulation and abscess formation. Through molecular studies, we identify IL-33, a cytokine with known pro-inflammatory and anti-inflammatory activities, and Cxcl1, a neutrophil-attracting chemokine, as potential weak and strong direct targets of Ovol1, respectively. Furthermore, we provide functional evidence that elevated Il33 expression reduces disease severity in imiquimod-treated Ovol1-deficient mice, whereas persistent accumulation and epidermal migration of neutrophils exacerbate it. Collectively, our study uncovers the importance of an epidermally expressed transcription factor that regulates both the integrity of the epidermal barrier and the behavior of neutrophils in psoriasis-like inflammation.
引用
- Dragan M, Sun P, Chen Z, et al. Epidermis-Intrinsic Transcription Factor Ovol1 Coordinately Regulates Barrier Maintenance and Neutrophil Accumulation in Psoriasis-Like Inflammation. J Invest Dermatol. 2021. PMID: 34461129. doi:10.1016/j.jid.2021.08.397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。